Symbol: SUNPHARMA
Month: 2024-07
Start Price: ₹1506.22
End Price: ₹1709.05
12M Return: 13.47%
6M Return: 13.47%
3M Return: 13.47%
Volatility: 0.189
Sharpe Ratio: 8.120
Max Drawdown: -0.016
Peer Correlation (DRREDDY): 0.3278
Peer Correlation (DIVISLAB): 0.6194
Peer Correlation (HINDUNILVR): -0.1016
Average Peer Correlation: 0.2819

Generate a short summary and suggest whether to BUY, SELL, or HOLD.

--- LLM Output ---
**Summary:**

Sun Pharma (SUNPHARMA) has delivered a strong performance over the past 12 months, with a return of 13.47%. The stock has shown low volatility, with a standard deviation of 0.189, and an impressive Sharpe Ratio of 8.120, indicating a high return per unit of risk. The maximum drawdown has been minimal at -0.016. In terms of peer correlation, Sun Pharma has a moderate correlation with DRREDDY (0.3278) and a high correlation with DIVISLAB (0.6194), while it has a negative correlation with HINDUNILVR (-0.1016).

**Recommendation:**

Based on the analysis, I would recommend a **BUY**. The stock's strong returns, low volatility, and high Sharpe Ratio indicate a favorable risk-return profile. The peer correlation analysis suggests that Sun Pharma is not overly dependent on its peers, which reduces the risk of sector-specific downturns. With a strong performance over the past 12 months, I believe the stock has momentum on its side, and investors may benefit from further upside. However, as with any investment, it's essential to conduct thorough research, consider your individual financial goals, and consult with a financial advisor before making a decision.